S

Shanghai Kinetic Medical Co Ltd
SZSE:300326

Watchlist Manager
Shanghai Kinetic Medical Co Ltd
SZSE:300326
Watchlist
Price: 6.63 CNY -1.34%
Market Cap: 4.8B CNY
Have any thoughts about
Shanghai Kinetic Medical Co Ltd?
Write Note
Shanghai Kinetic Medical Co Ltd
/
Income Statement
/
Revenue

Shanghai Kinetic Medical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Kinetic Medical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Kinetic Medical Co Ltd
SZSE:300326
Revenue
¥969.9m
CAGR 3-Years
-8%
CAGR 5-Years
-3%
CAGR 10-Years
19%
A
APT Medical Inc
SSE:688617
Revenue
¥1.7B
CAGR 3-Years
51%
CAGR 5-Years
47%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Revenue
¥7.3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
16%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Revenue
¥37.1B
CAGR 3-Years
15%
CAGR 5-Years
19%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Revenue
¥2.6B
CAGR 3-Years
3%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Revenue
¥11.4B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai Kinetic Medical Co Ltd
Glance View

Market Cap
4.8B CNY
Industry
Health Care

Shanghai Kinetic Medical Co., Ltd. engages in the research, development, manufacture and sale of medical devices dedicated to serve orthopedic minimally invasive surgerical needs. The company is headquartered in Shanghai, Shanghai and currently employs 1,107 full-time employees. The company went IPO on 2012-06-13. The firm is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The firm operates its business in domestic market.

Intrinsic Value
6 CNY
Overvaluation 10%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is Shanghai Kinetic Medical Co Ltd's Revenue?
Revenue
969.9m CNY

Based on the financial report for Sep 30, 2024, Shanghai Kinetic Medical Co Ltd's Revenue amounts to 969.9m CNY.

What is Shanghai Kinetic Medical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
19%

Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Shanghai Kinetic Medical Co Ltd have been -8% over the past three years , -3% over the past five years , and 19% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.